Severe cholestatic hepatitis caused by thiazolidinediones: Risks associated with substituting rosiglitazone for troglitazone

Digestive Diseases and Sciences

Volumn 47, Issue 7, 2002, Pages 1632-1637

  Bonkovsky, Herbert L ^a   Azar, Riad ^a   Bird, Steven ^a   Szabo, Gyongyi ^a   Banner, Barbara ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Rosiglitazone; Severe cholestatic hepatitis; Thiazolidinediones; Troglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AZATHIOPRINE; GAMMA GLUTAMYLTRANSFERASE; PREDNISONE; ROSIGLITAZONE; TROGLITAZONE; URSODEOXYCHOLIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; CLINICAL EXAMINATION; DRUG WITHDRAWAL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ALKALINE PHOSPHATASE; CHOLESTASIS; CHROMANS; FEMALE; HEPATITIS, TOXIC; HUMANS; HYPOGLYCEMIC AGENTS; LIVER FUNCTION TESTS; MIDDLE AGED; THIAZOLES; THIAZOLIDINEDIONES; TRANSAMINASES;

EID: 0036311065     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015895925374     Document Type: Article

References (20)

1. Unraveling the mechanism of action of thiazolidinediones
2. Lessons from the glitazones: A story of drug development
3. Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone
4. Troglitazone-induced hepatic failure leading to liver transplantation: A case report
5. Hepatic dysfunction associated with troglitazone
6. Severe hepatotoxicity associated with troglitazone
7. Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration
8. Hepatic failure in a patient taking rosiglitazone
9. Hepatocellular-injury in a patient receiving rosiglitazone: A case report
10. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes
11. The role of conjugation in hepatotoxicity of troglitazone in human and porcine hepatocyte cultures
12. Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus
13. Drug-induced liver disease
14. Troglitazone-associated hepatotoxicity treated successfully with steroids
15. Rosiglitazone therapy is not associated with hepatotoxicity
16. Rosiglitazone and hepatic failure
17. The natural history of histologically proved drug induced liver disease
18. Non-alcoholic steatohepatitis (NASH): A disorder of emerging identity and importance